Category | Pharma

Pfizer creates breaking news with Allergan purchase

Posted on 23 November 2015

US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history.

Tags: , , ,

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

Posted on 10 August 2015

An interview with Richard Brudnick, Senior VP, Corporate Development, Biogen De-risking has evolved from literature searches to the cultivation of many wide-ranging relationships throughout the life sciences strata, according to Richard Brudnick, Senior VP, Corporate Development at Biogen. In a recent interview, Brudnick outlined key strategies to accessing innovation and “de-risking” risk through collaboration.

Tags: , , , ,

Pfizer in asset purchase and option to acquire AM-Pharma

Posted on 12 May 2015

Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company.

Tags: ,

Roche and 4D Molecular partner for AAV vectors

Posted on 30 April 2015

4D Molecular Therapeutics announced a collaboration and license agreement with Roche to discover and develop optimized next-generation AAV vectors

Tags: , ,

GW Pharma brings in $179mn in public offering

Posted on 30 April 2015

GW will issue 1,600,000 American Depositary Shares (“ADSs”), representing 19,200,000 ordinary shares of GW, at a price to the public of $112.00 per ADS on the NASDAQ Global Market


AstraZeneca and Innate Pharma in IPH2201 deal

Posted on 28 April 2015

Innate Pharma has signed a co-development and commercialization agreement with AstraZeneca

Tags: , ,

Celgene and AstraZeneca in MEDI4736 pact

Posted on 28 April 2015

Celgene has entered into a strategic collaboration with MedImmune to develop and commercialize an anti-PD-L1 inhibitor, MEDI4736, for hematologic malignancies

Tags: , ,

Roche and Curevac partner for IDO1 and TDO inhibitors

Posted on 21 April 2015

Curadev Pharma has entered into a research collaboration and license agreement with Roche for development and commercialization of IDO1 and TDO inhibitors

Tags: , ,

Merck and Tetralogic in solid tumor clinical pact

Posted on 21 April 2015

TetraLogic and Merck will collaborate on a Phase 1 study

Tags: , ,

Takeda and CiRA enter iPS cell research pact

Posted on 20 April 2015

Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical will work together to develop clinical applications of induced pluripotent stem cells

Tags: , ,